药学干预对多药联合治疗2型糖尿病患者疗效的影响  

Influence of Pharmaceutical Intervention to accept Multi drug Treatment for Patients with type 2 Diabetes Mellitus

作　　者：彭菲[1] 刘明铭[1] 宗晓芸 田洁[1] 

机构地区：[1]深圳市第二人民医院,广东深圳518035

出　　处：《中国药物经济学》2015年第4期137-138,共2页China Journal of Pharmaceutical Economics

摘　　要：目的探讨药学干预对多药联合治疗2型糖尿病患者疗效的影响。方法收集101例2型糖尿病患者资料,将患者分为药学干预组(A组,57例)和对照组(B组,44例)。比较两组患者治疗效果、用药偏差发生率,记录其用药依从性。结果 A组患者总有效率为96.5%,明显高于B组的79.5%(P<0.05);A组用药偏差发生率明显低于B组(P<0.05);A组用药依从优良率为93.0%,明显高于B组的72.7%(P<0.05)。结论对多药联合治疗的2型糖尿病患者予以药学干预,可有效提高患者服药依从性及治疗效果,并降低药物不良反应发生率。Objective To investigate the influence of pharmacy intervention accept multi drug treatment for patients with type 2 diabetes melitus.Methods We selected 101 cases of patients with type 2 diabetes,patients wil be divided into pharmaceutical intervention group（group A,n=57）and control group（group B,n=44）.Comparison of two groups of patients treatment effect,the incidence of medication deviation,recorded their medication compliance. Results A group of patients,the total effective rate was 96.5%,obviously higher than that of B group 79.5%（P〈0.05）; in group A were significantly lower than B group deviation（P〈0.05）;A group of compliance for the excelent and good rate was 93.0%,higher than that in B group and 72.7%（P〈0.05）.Conclusion The pharmacy intervention to be accepted multi-drug combination therapy in patients with type 2 diabetes,which can effectively improve their medication compliance,treatment and reduce the incidence of adverse drug reactions.

关 键 词：药学干预 多药联合 2型糖尿病 

分 类 号：R587.1[医药卫生—内分泌]